These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23760135)

  • 1. Generation of statin drug metabolites through electrochemical and enzymatic oxidations.
    Khera S; Hu N
    Anal Bioanal Chem; 2013 Jul; 405(18):6009-18. PubMed ID: 23760135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
    Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
    Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin.
    Silva TD; Oliveira MA; de Oliveira RB; Vianna-Soares CD
    J Chromatogr Sci; 2012 Oct; 50(9):831-8. PubMed ID: 22689902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers:gut hydrolysis of lovastatin is twice that of simvastatin.
    Vree TB; Dammers E; Ulc I; Horkovics-Kovats S; Ryska M; Merkx I
    ScientificWorldJournal; 2003 Dec; 3():1332-43. PubMed ID: 14755114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Oxidation of simvastatin in mouse liver preparations.
    Prueksaritanont T; Ma B; Fang X; Subramanian R; Yu J; Lin JH
    Drug Metab Dispos; 2001 Oct; 29(10):1251-5. PubMed ID: 11560866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
    Nordin C; Dahl ML; Eriksson M; Sjöberg S
    Lancet; 1997 Jul; 350(9070):29-30. PubMed ID: 9217719
    [No Abstract]   [Full Text] [Related]  

  • 7. Fragmentation study of simvastatin and lovastatin using electrospray ionization tandem mass spectrometry.
    Wang H; Wu Y; Zhao Z
    J Mass Spectrom; 2001 Jan; 36(1):58-70. PubMed ID: 11180647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M; Rollini M
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
    Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic acylation and ring-closing olefin metathesis: a convenient strategy for the lactone moiety of compactin and mevinolin.
    Ghosh AK; Lei H
    J Org Chem; 2000 Jul; 65(15):4779-81. PubMed ID: 10959897
    [No Abstract]   [Full Text] [Related]  

  • 11. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP109E1 is a novel versatile statin and terpene oxidase from Bacillus megaterium.
    Putkaradze N; Litzenburger M; Abdulmughni A; Milhim M; Brill E; Hannemann F; Bernhardt R
    Appl Microbiol Biotechnol; 2017 Dec; 101(23-24):8379-8393. PubMed ID: 29018905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions in solution between cyclodextrins and statins].
    Süle A; Szente L; Csempesz F
    Acta Pharm Hung; 2005; 75(4):179-83. PubMed ID: 16711394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
    Vickers S; Duncan CA; Vyas KP; Kari PH; Arison B; Prakash SR; Ramjit HG; Pitzenberger SM; Stokker G; Duggan DE
    Drug Metab Dispos; 1990; 18(4):476-83. PubMed ID: 1976071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug interactions that interfere with statin metabolism.
    Hirota T; Ieiri I
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1435-47. PubMed ID: 26058399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin production: From molecular basis to industrial process optimization.
    Mulder KC; Mulinari F; Franco OL; Soares MS; Magalhães BS; Parachin NS
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):648-65. PubMed ID: 25868803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ; Keller U; Oberhänsli A; Riesen WF
    Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic interactions with statins].
    Molden E; Asberg A
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):189-93. PubMed ID: 11475198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.